Pages that link to "Q34801327"

The following pages link to Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi-component toxin LukGH. (Q34801327):

Displaying 23 items.

• Antimicrobial Mechanisms of Macrophages and the Immune Evasion Strategies of Staphylococcus aureus (Q26774998) (← links)
• The role of genetics and antibodies in sepsis (Q28075279) (← links)
• Staphylococcus aureus Pore-Forming Toxins. (Q30152755) (← links)
• Staphylococcus aureus Leukocidin A/B (LukAB) Kills Human Monocytes via Host NLRP3 and ASC when Extracellular, but Not Intracellular (Q35662239) (← links)
• Context matters: The importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies. (Q36088381) (← links)
• Crystal structures of the components of the Staphylococcus aureus leukotoxin ED. (Q36588360) (← links)
• Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis (Q36636170) (← links)
• Inflammasome Activation Can Mediate Tissue-Specific Pathogenesis or Protection in Staphylococcus aureus Infection (Q37486275) (← links)
• Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors. (Q38728618) (← links)
• Monoclonal Antibodies Against the Staphylococcus aureus Bicomponent Leukotoxin AB Isolated Following Invasive Human Infection Reveal Diverse Binding and Modes of Action (Q38967812) (← links)
• Above and beyond C5a Receptor Targeting by Staphylococcal Leucotoxins: Retrograde Transport of Panton-Valentine Leucocidin and γ-Hemolysin (Q39002180) (← links)
• Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity (Q39264668) (← links)
• Structure and Function of the Two-Component Cytotoxins of Staphylococcus aureus - Learnings for Designing Novel Therapeutics (Q39271777) (← links)
• Control of Phagocytosis by Microbial Pathogens. (Q44612676) (← links)
• Disarming Staphylococcus aureus from destroying human cells by simultaneously neutralizing six cytotoxins with two human monoclonal antibodies. (Q55074495) (← links)
• Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases. (Q55515231) (← links)
• Membrane insertion of α-xenorhabdolysin in near-atomic detail (Q56535157) (← links)
• Inhibition of bacterial toxin recognition of membrane components as an anti-virulence strategy (Q64255131) (← links)
• Unbiased Identification of Immunogenic Staphylococcus aureus Leukotoxin B-Cell Epitopes (Q89516785) (← links)
• Structure-based discovery of a small-molecule inhibitor of methicillin-resistant Staphylococcus aureus virulence (Q90370773) (← links)
• Molecular mechanism of leukocidin GH-integrin CD11b/CD18 recognition and species specificity (Q92094612) (← links)
• Staphylococcus aureus Secreted Toxins and Extracellular Enzymes (Q92380520) (← links)
• Rational Design of Toxoid Vaccine Candidates for Staphylococcus aureus Leukocidin AB (LukAB) (Q92815271) (← links)